Vascular News and Research

RSS
OXiGENE reports $2.5M net income for second-quarter 2010 vs. $5.3M net loss for same period in 2009

OXiGENE reports $2.5M net income for second-quarter 2010 vs. $5.3M net loss for same period in 2009

Research identifies intracellular mechanism for altering blood vessels permeability for tumours treatment

Research identifies intracellular mechanism for altering blood vessels permeability for tumours treatment

Clinical cases that use IQQA-Liver for operative assessments exceed 1000: EDDA Technology

Clinical cases that use IQQA-Liver for operative assessments exceed 1000: EDDA Technology

Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots

Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots

Endologix responds to Bard Peripheral Vascular's patent infringement lawsuit

Endologix responds to Bard Peripheral Vascular's patent infringement lawsuit

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Cardiovascular Systems fourth-quarter revenue increases 15% to $18.0 million

Cardiovascular Systems fourth-quarter revenue increases 15% to $18.0 million

China Pharma second-quarter revenue increases 22% to $16.6 million

China Pharma second-quarter revenue increases 22% to $16.6 million

Older Americans suffer from full-blown depression: Report

Older Americans suffer from full-blown depression: Report

New scaffold supports growth, integration of stem cell-derived cardiac muscle cells

New scaffold supports growth, integration of stem cell-derived cardiac muscle cells

Hemodialysis with AVF depends on patient’s health insurance: Study

Hemodialysis with AVF depends on patient’s health insurance: Study

Aptus reports successful treatment with EndoStapling System in Europe

Aptus reports successful treatment with EndoStapling System in Europe

Vanguard to acquire assets of Arizona Heart Hospital

Vanguard to acquire assets of Arizona Heart Hospital

EpiCept second-quarter net loss decreases to $4.9 million

EpiCept second-quarter net loss decreases to $4.9 million

Medtronic completes enrollment in Complete SE vascular stent superficial femoral artery clinical study

Medtronic completes enrollment in Complete SE vascular stent superficial femoral artery clinical study

Eliminating depression, diabetes can reduce levels of dementia: Study

Eliminating depression, diabetes can reduce levels of dementia: Study

New article highlights importance of patient safety features in design of IV needleless connectors

New article highlights importance of patient safety features in design of IV needleless connectors

New studies question wide-spread hypothesis that CCSVI contribute to development of MS

New studies question wide-spread hypothesis that CCSVI contribute to development of MS

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.